Facts, Myths and Excuses: Navigating Challenges in Point-of-Care Testing

Prepare for the excuses before they arrive—Dispel myths, expose tricks, and strengthen your testing process.  Every collector, clinician, or program manager has heard an excuse from a donor attempting to avoid a positive result at one point in their careers. Excuses and myths around point-of-care drug testing for drugs of abuse are as common as the tests themselves. From claims of secondhand smoke exposure to blaming over-the-counter medications, patients and donors often have ready-made explanations.
This webinar explores the most common myths, misconceptions, and excuses in rapid drug testing—including cross-reactivity concerns, false positives, window of detection misunderstandings, environmental exposure claims, and specimen adulteration attempts. We’ll break down what’s fact versus fiction, give you tools to confidently address these challenges, and open the floor for attendees to share their own experiences and solutions.
By the end, you’ll leave with practical strategies to dispel myths, recognize manipulations, and handle excuses with professionalism and clarity.

Expectations: Understanding the Limitations of Point-of-Care Testing

Not all tests are created equal. In this free live webinar, you’ll uncover the benefits, science ,and shortfalls of rapid diagnostic testing. Hosted by Chief Product Officer, Eric Malis, we’ll cover everything from detection windows to cross-reactions and the importance of setting the right expectations. Don’t miss this opportunity to sharpen your knowledge and make better-informed testing decisions.

Beyond the Rapid Test: The Critical Role of Lab Confirmations in Toxicology

When a rapid toxicology test yields a positive result, the next step is crucial—confirmation through laboratory testing. While rapid tests provide quick insights, they can sometimes lead to false positives or incomplete data, impacting critical decisions in healthcare, workplace safety, and legal settings. This webinar will explore the importance of lab confirmations, the science behind definitive testing methods, and the potential consequences of relying solely on preliminary results.

2024 Drug Trends and Emerging Threats Report

Join us for an exclusive webinar uncovering the DEA’s 2024 Emerging Drug Threats and Trends Report. Gain crucial insights into the latest drug trends impacting communities across the United States. Learn about evolving substances, public health concerns, and how these issues shape enforcement and prevention strategies. Stay informed and prepared and don’t miss this opportunity to understand the critical challenges and solutions shaping our fight against drug abuse.

 

Sources:

DEA 2024 NDTA Report

DEA 2022 Emerging Threat Report

DEA 2024 STREET Report

U.S. Customs and Border Protection (CBP) Drug Seizures

 

Slide Deck:

2024 Emerging Drug Threats

Kratom Revisited: Latest Insights on Use, Effects, and Legal Status

Join our Chief Product Officer, Eric Malis, as he delves into the world of Kratom in this live recorded educational webinar. Gain key insights into its usage trends, potential effects, legal challenges, and advancements in drug testing. This is a must watch for anyone seeking clarity on this controversial substance.